Pharmaceutical Industry Payments to Professional Medical Societies in Japan

Anju Murayama^{1

2}, Kenichi Higuchi³, Yuki Senoo⁴

Affiliations

¹ School of Medicine, Tohoku University, Sendai City, Miyagi, Japan. anju.murayama.s8@dc.tohoku.ac.jp.
² Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. anju.murayama.s8@dc.tohoku.ac.jp.
³ School of Medicine, Tohoku University, Sendai City, Miyagi, Japan.
⁴ Higashi Totsuka Memorial Hospital, Yokohama, Kanagawa, Japan.

Anju Murayama et al. J Gen Intern Med. 2024 Jun.

. 2024 Jun;39(8):1534-1535.

doi: 10.1007/s11606-024-08735-5. Epub 2024 Mar 22.

Anju Murayama^{1

2}, Kenichi Higuchi³, Yuki Senoo⁴

¹ School of Medicine, Tohoku University, Sendai City, Miyagi, Japan. anju.murayama.s8@dc.tohoku.ac.jp.
² Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA. anju.murayama.s8@dc.tohoku.ac.jp.
³ School of Medicine, Tohoku University, Sendai City, Miyagi, Japan.
⁴ Higashi Totsuka Memorial Hospital, Yokohama, Kanagawa, Japan.

No abstract available

Conflict of interest statement

The authors declare that they do not have a conflict of interest.

1. Murayama A, Shin N, Higuchi K, Kohli I, Kugo H, Senoo Y. Financial conflicts of interest between infectious diseases clinical practice guideline authors and the pharmaceutical industry in Japan. Infect Dis (Lond). 2024:1–5. - PubMed
1. Boytchev H. Medical royal colleges receive millions from drug and medical devices companies. Bmj. 2023;382:1658. doi: 10.1136/bmj.p1658. - DOI - PubMed
1. Murayama A, Saito H, Tanimoto T, Ozaki A. Financial conflicts of interest between pharmaceutical companies and executive board members of internal medicine subspecialty societies in Japan between 2016 and 2020. J Eval Clin Pract. 2023;29(6):883–886. doi: 10.1111/jep.13877. - DOI - PubMed
1. Ozieranski P, Saito H, Rickard E, Mulinari S, Ozaki A. International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency. Global Health. 2023;19(1):14. doi: 10.1186/s12992-022-00902-9. - DOI - PMC - PubMed
1. Murayama A, Kamamoto S, Kugo H, Saito H, Ozaki A. Research and Nonresearch Industry Payments to Nephrologists in the United States between 2014 and 2021. J Am Soc Nephrol. 2023;34(10):1709–1720. doi: 10.1681/ASN.0000000000000172. - DOI - PMC - PubMed